B O O K - American College of Rheumatology
B O O K - American College of Rheumatology
B O O K - American College of Rheumatology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
abstract KEYWORD INDEX<br />
K/BxN 1417<br />
K2P5.1 1255<br />
kappa score 522<br />
Karn<strong>of</strong>sky performance status 1204<br />
Kawasaki disease 249, 267, 652, 828, 1680,<br />
2202<br />
kidney disease 857<br />
kinase 273, 286, 493, 635, 1119, 1493, 1513,<br />
1516, 2234<br />
kinase inhibitor 273, 288, 1107<br />
KIR (Killer Ig like receptor) 1966<br />
knee 131, 140, 180, 191, 194, 200, 201, 682,<br />
684, 693, 708, 941, 943, 947, 963, 1382, 1385,<br />
1558, 2052, 2053, 2054, 2055, 2059, 2061,<br />
2094, 2096, 2098, 2101, 2132, 2134, 2244<br />
knee loading 2099<br />
knee osteoarthritis 186, 189, 2059, 2100<br />
knee pain 685<br />
knockout line 854<br />
knowledge 1009<br />
knowledge transfer 984<br />
L 1073<br />
La/SSB 2175<br />
labial salivary gland 1900<br />
laboratory tests 312, 378, 909, 1293, 1359,<br />
1765, 1845<br />
language 1024<br />
laser Doppler imaging 579<br />
laser Doppler perfusion imaging 574<br />
late onset rheumatoid arthritis 1061<br />
latent tuberculosis infection (LTBI) 699, 782<br />
latitudes variation 783<br />
lecithin cholesterol acyl:transferas 1058<br />
leflunomide 75, 229, 319, 1796<br />
lenalidomide 1699<br />
lentivirus 1729<br />
leukocyte homing 860<br />
levamisole 2013<br />
LFA-1 503<br />
lidocaine patch 5% 944<br />
lipase 438<br />
lipids 86, 345, 385, 393, 438, 471, 1000, 1019,<br />
1030, 1033, 1064, 1187<br />
literature search 1291<br />
liver fibrosis 129<br />
liver function 319<br />
loading 190<br />
localized scleroderma 1683, 2006<br />
long term 97<br />
K<br />
L<br />
longitudinal studies 77, 110, 380, 731, 779,<br />
1219, 1400, 1406, 1459, 1541, 1548, 1685,<br />
1854, 1951, 2064, 2079<br />
long-term outcome 380, 1683<br />
low back pain 1458<br />
low disease activity 1826<br />
low dose 1944<br />
low dose aspirin 945<br />
low dose strategy 290<br />
low-field MRI 138<br />
lumbar disc herniation 1921<br />
lung 563, 596, 604, 605, 622, 704, 724, 852,<br />
907, 924, 1022, 1086, 1176, 1212, 1635, 1739,<br />
1989, 2119, 2194<br />
lupus 2189<br />
lupus anticoagulant 4, 12<br />
lupus arthritis 446<br />
lupus gradient 510<br />
lupus nephritis 268, 423, 430, 433, 434, 435,<br />
440, 467, 469, 477, 851, 867, 1140, 1144, 1151,<br />
1173, 1251, 1398, 1399, 1402, 1403, 1414,<br />
1453, 1455, 1702, 1866, 2085, 2104, 2121,<br />
2186, 2188<br />
Lyme arthritis 1638<br />
Lyme disease 1320, 1638, 1644<br />
lymph node 1069, 1710<br />
lymphadenopathy 903<br />
lymphatic draining 1710<br />
lymphocytes 422, 463, 492, 747, 846<br />
lymphocytopenia 316<br />
lymphoid neogenesis 1906<br />
lymphoma 398, 720, 1015, 1884, 1888, 1912,<br />
1914, 1916<br />
lymphotoxin 1885<br />
lymphotoxin alpha 1122<br />
M<br />
machine learning 1403<br />
macromolecular therapy 423<br />
macrophage activation syndrome 18, 208, 653,<br />
903, 1354, 1664, 1668<br />
macrophage migration 1718<br />
macrophage migration inhibitory factor (MIF)<br />
903<br />
macrophages 23, 273, 283, 359, 844, 845, 847,<br />
853, 854, 859, 861, 1100, 1135, 1353, 1506,<br />
1522, 1613, 1718, 1723, 1761, 1798, 1965,<br />
1993, 2230, 2276<br />
magnetic resonance imaging (MRI) 122, 123,<br />
125, 126, 127, 130, 132, 133, 134, 135, 137,<br />
138, 141, 142, 182, 188, 193, 197, 228, 461,<br />
524, 540, 551, 553, 650, 667, 706, 709, 921,<br />
938, 1159, 1167, 1170, 1293, 1369, 1370, 1371,<br />
1372, 1373, 1380, 1625, 1682, 1779, 1817,<br />
1929, 1934, 1957, 1958, 1959, 1963, 2100<br />
maintenance treatment 2041<br />
MAIT cell 2232<br />
major histocompatibility complex (MHC) 502,<br />
1281, 1579, 1979, 2185<br />
malalignment 131, 2100<br />
male vs female 1158<br />
malignancy 62, 214, 398, 407, 408, 468, 580,<br />
720, 731, 883, 996, 1899, 2084<br />
mammalian target <strong>of</strong> rapamycin (mTOR) 1530<br />
managed care 757, 764<br />
management 888<br />
manzamine A 1131<br />
MAP kinases 17, 39<br />
MAPK 632<br />
MAPKK 635<br />
mass communication 2081<br />
mast cells 28, 333, 896, 1449, 1732<br />
matrix metalloproteinase (MMP) 21, 267, 366,<br />
541, 1086, 1292, 1388, 1466, 1472, 1481, 1491,<br />
1497, 1530, 1628, 1797, 1800<br />
MCTD 608, 852<br />
MDRD 147<br />
measure 1927<br />
measurement scales 2065<br />
mediation analysis 1461<br />
medical resident 46, 48, 1431, 1432<br />
medication 1001<br />
medication adherence 1404<br />
medication compliance 338, 1056<br />
medication cost 1462<br />
membrane attack complex 846, 1262<br />
memory 1159<br />
men 1546<br />
meniscal tear 202, 885<br />
meniscectomy 167, 192<br />
menopause 301, 2245<br />
mental health status 2070<br />
mepolizumab 2203<br />
mesenchymal stem cells 630, 840, 918, 1134,<br />
1143, 1182, 1247, 1382, 1475, 1490, 1498<br />
messenger RNA (mRNA) 2008, 2219, 2276<br />
meta-analysis 168, 412, 419, 720, 824, 1574,<br />
1657, 1795, 2145, 2155<br />
metabolic syndrome 445, 476, 547, 871, 888,<br />
1177, 1178, 1507, 1667<br />
metabolomics 711<br />
metacarpophalangeal joints 1634<br />
metalloproteases 1484<br />
methionine sulfoxide reductase A (MsrA) 1599<br />
methodology 952<br />
methotrexate (MTX) 40, 74, 129, 220, 230,<br />
253, 254, 284, 302, 319, 335, 377, 380, 388,<br />
394, 396, 397, 417, 664, 827, 1009, 1060, 1096,<br />
1101, 1106, 1117, 1333, 1392, 1393, 1394,<br />
1395, 1439, 1596, 1670, 1796, 1806, 1812,<br />
1815, 1836, 2171, 2267<br />
methotrexate polyglutamates (MTXPG) 302<br />
methotrexate responder 1392<br />
366<br />
2010 Program Book
Change language